Saturday, 24 November 2018 20:17

Anticoagulation news items. Week commencing 19th November 2018

Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis

JAMA Cardiology

This review of 3 RCTs (n=3943) comparing bare-metal stents (BMSs) to drug-eluting stents (DESs) with shortened duration of dual antiplatelet therapy (one month only) found DES were associated with lower risk of major adverse cardiac events and other adverse outcomes.



The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at: